← Open Payments lookup

ANGELA RAAB: Open Payments

NPI 1801500087 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,452 in 81 payments from 16 companies in 2025. Trend: 2023 $663 · 2024 $1,297 · 2025 $1,452

Food & beverage: $1,367Education: $85
CompanyPaymentsAmount
Astellas Pharma US Inc12$240
Bayer Healthcare Pharmaceuticals Inc.8$183
ABBVIE INC.11$170
AstraZeneca Pharmaceuticals LP8$152
Amgen Inc.13$151
Novo Nordisk Inc6$139
Lilly USA, LLC8$124
PFIZER INC.5$92
Exact Sciences Corporation2$62
Kowa Pharmaceuticals America, Inc.2$32

Products named: Kerendia, Veozah, FARXIGA, MOUNJARO, OTEZLA, Ozempic, QULIPTA, The Cologuard Plus Collection Kit.

Industry payments across MD — which companies pay providers there.